Search research articles
Contact Us
Filters
Showing results (41-50 of 76) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1991
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy
G L Phillips, J D Shepherd, M J Barnett, et al.
Bone Marrow Transplantation
|
October 24, 2000
Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer
D E Reece, K A Foon, M Bhattacharya-Chatterjee, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
April 1, 1990
Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation
H G Klingemann, A C Eaves, M J Barnett, et al.
Leukemia & Lymphoma
|
October 1, 1995
Acute monocytic leukemia: a single institution experience
H Fung, J D Shepherd, S C Naiman, et al.
Blood
|
March 1, 1994
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy
D E Reece, J M Connors, J J Spinelli, et al.
British Journal of Cancer
|
September 1, 1993
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours
M J Barnett, C M Coppin, N Murray, et al.
Leukemia & Lymphoma
|
February 1, 1995
Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992
H Tezcan, M J Barnett, C N Bredeson, et al.
Bone Marrow Transplantation
|
December 1, 1991
Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group
G L Phillips, M J Barnett, M C Brain, et al.
Blood
|
July 15, 1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy
D E Reece, M J Barnett, J D Shepherd, et al.
Bone Marrow Transplantation
|
July 1, 1989
Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture
M J Barnett, C J Eaves, G L Phillips, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 76) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1991
Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy
G L Phillips, J D Shepherd, M J Barnett, et al.
Bone Marrow Transplantation
|
October 24, 2000
Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer
D E Reece, K A Foon, M Bhattacharya-Chatterjee, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
April 1, 1990
Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation
H G Klingemann, A C Eaves, M J Barnett, et al.
Leukemia & Lymphoma
|
October 1, 1995
Acute monocytic leukemia: a single institution experience
H Fung, J D Shepherd, S C Naiman, et al.
Blood
|
March 1, 1994
Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy
D E Reece, J M Connors, J J Spinelli, et al.
British Journal of Cancer
|
September 1, 1993
High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours
M J Barnett, C M Coppin, N Murray, et al.
Leukemia & Lymphoma
|
February 1, 1995
Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992
H Tezcan, M J Barnett, C N Bredeson, et al.
Bone Marrow Transplantation
|
December 1, 1991
Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group
G L Phillips, M J Barnett, M C Brain, et al.
Blood
|
July 15, 1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy
D E Reece, M J Barnett, J D Shepherd, et al.
Bone Marrow Transplantation
|
July 1, 1989
Successful autografting in chronic myeloid leukaemia after maintenance of marrow in culture
M J Barnett, C J Eaves, G L Phillips, et al.
Page
of 8